Target intelligence / Profile preview

Mitochondrial ribosomal protein L40 (MRPL40)

Target
MRPL40
Molecular classification
Other (mitochondrial ribosomal protein), Ribosomal protein, 39S subunit protein
01

Overview

Mitochondrial ribosomal protein L40 (MRPL40) is a nuclear-encoded protein that forms part of the large (39S) subunit of the mitochondrial ribosome in eukaryotes, where it is essential for protein synthesis within the mitochondrion[2][3]. The mammalian mitoribosome differs significantly from prokaryotic ribosomes in composition and sequence, with MRPL40 contributing to translation of mitochondrially encoded proteins, particularly those involved in oxidative phosphorylation. Defects or deletions in the MRPL40 gene are associated with mitochondrial diseases and are implicated in congenital syndromes such as velo-cardio-facial syndrome and DiGeorge syndrome[2][3]. There is currently no evidence that MRPL40 is a therapeutic target for small-molecule drugs or biologics[2][3].

Other names
MRP-L40MRPL22MRP-L22NLVCFURIML40mtmL4039S ribosomal protein L40, mitochondrialLarge ribosomal subunit protein mL40nuclear localization signal-containing protein deleted in velocardiofacial syndromeup-regulated in metastasis
02

Biological functions

Mitochondrial protein synthesisMitochondrial translationAssembly of mitochondrial oxidative phosphorylation complexesRNA binding
03

Disease associations

Mitochondrial diseaseMitochondrial complex I deficiencyVelo-cardio-facial syndromeDiGeorge syndrome
04

Safety considerations

Deletion may contribute to congenital syndromes affecting multiple systems (e.g., velo-cardio-facial syndrome, DiGeorge syndrome)

Beyond the preview

Go deeper on Mitochondrial ribosomal protein L40 (MRPL40).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein L40 (MRPL40).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call